{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:29:06Z","timestamp":1793744946026,"version":"4.6.1"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ctro.2026.101260","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:41:00Z","timestamp":1786405260000},"page":"101260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reirradiation of recurrent brain tumors: a review by the ESTRO CNS Focus Group"],"prefix":"10.1016","volume":"62","author":[{"given":"Raffaella","family":"De Pietro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Harat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthica","family":"Indramohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kazda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavka","family":"Lukacova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrada","family":"Turcas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-1755","authenticated-orcid":false,"given":"Felix","family":"Ehret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-023-04407-2","article-title":"The evolving role of reirradiation in the management of recurrent brain tumors","volume":"164","author":"De Pietro","year":"2023","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0010","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/S1470-2045(25)00562-5","article-title":"Reirradiation Collaborative Group (ReCOG) consensus on standards for dose evaluation and reporting in patients with multiple courses of radiation therapy: an AAPM\/ACRO\/ASTRO\/CARO\/COMP\/CADRA\/CPQR\/ESTRO\/NRG-endorsed consensus statement","volume":"27","author":"Paradis","year":"2026","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2026.101260_bb0015","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101260_bb0020","first-page":"630","article-title":"Reirradiation: standards, challenges, and patient-focused strategies across tumor types","volume":"75","author":"Beddok","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.ctro.2026.101260_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14338\/IJPT-18-00045.1","article-title":"Clinical outcomes of recurrent intracranial meningiomas treated with proton beam reirradiation","volume":"5","author":"Imber","year":"2019","journal-title":"Int J Part Ther"},{"issue":"5","key":"10.1016\/j.ctro.2026.101260_bb0030","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/cam4.1425","article-title":"Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score\u2014report of the Radiation Oncology Group of the German Cancer Consortium","volume":"7","author":"Combs","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.ctro.2026.101260_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111299","article-title":"Patterns of care in primary brain tumour reirradiation: a survey by the ESTRO CNS focus group","volume":"214","author":"Turcas","year":"2026","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0040","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose\u2013volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2026.101260_bb0045","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.rpor.2020.04.020","article-title":"Radiotherapy for the treatment of pituitary adenomas: a dosimetric comparison of three planning techniques","volume":"25","author":"Ramos-Prudencio","year":"2020","journal-title":"Rep Pract Oncol Radiother."},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2018.01.053","article-title":"Single- and multi-fraction stereotactic radiosurgery dose tolerances of the optic pathways","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101260_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110696","article-title":"ESTRO\/EANO recommendation on reirradiation of glioblastoma","volume":"204","author":"Andratschke","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101260_bb0060","doi-asserted-by":"crossref","first-page":"e1117","DOI":"10.1016\/j.wneu.2023.04.075","article-title":"Clinical efficacy of adjuvant radiotherapy for World Health Organization grade II intracranial meningioma","volume":"175","author":"Palmieri","year":"2023","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ctro.2026.101260_bb0065","series-title":"Meningiomas","first-page":"163","article-title":"Meningioma pathology and radiotherapy at initial diagnosis","author":"Minniti","year":"2024"},{"key":"10.1016\/j.ctro.2026.101260_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110271","article-title":"Re-irradiation for recurrent intracranial meningiomas: analysis of clinical outcomes and prognostic factors","volume":"195","author":"Desideri","year":"2024","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ijrobp.2024.10.034","article-title":"Radiation therapy for meningiomas \u2013 where do we stand and what\u2019s on the horizon?","volume":"121","author":"Ehret","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101260_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.adro.2026.102077","article-title":"Rinse and repeat? The role of reirradiation in meningiomas \u2013 a systematic review and meta-analysis","author":"Lutze","year":"2026","journal-title":"Adv Radiat Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101260_bb0085","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","author":"Goldbrunner","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ctro.2026.101260_bb0090","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3171\/sup.2004.101.supplement3.0390","article-title":"Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance","volume":"101(Suppl 3)","author":"Shrieve","year":"2004","journal-title":"J Neurosurg."},{"issue":"1100","key":"10.1016\/j.ctro.2026.101260_bb0095","doi-asserted-by":"crossref","first-page":"20190113","DOI":"10.1259\/bjr.20190113","article-title":"Dosimetric comparison of protons vs photons in re-irradiation of intracranial meningioma","volume":"92","author":"Poel","year":"2019","journal-title":"Br J Radiol"},{"issue":"9","key":"10.1016\/j.ctro.2026.101260_bb0100","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jocn.2012.01.023","article-title":"Reirradiation of recurrent meningioma","volume":"19","author":"Wojcieszynski","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ctro.2026.101260_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2016.12.014","article-title":"Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery","volume":"153","author":"Kim","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0110","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijrobp.2018.05.011","article-title":"Radiologic response and disease control of recurrent intracranial meningiomas treated with reirradiation","volume":"102","author":"Lin","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13014-024-02486-7","article-title":"Re-irradiation of anaplastic meningioma: higher dose and concomitant bevacizumab may improve progression-free survival","volume":"19","author":"Haisraely","year":"2024","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0120","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijrobp.2024.04.016","article-title":"Salvage stereotactic radiosurgery for recurrent WHO grade 2 and 3 meningiomas: a multicenter study (STORM)","volume":"120","author":"Gallitto","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-018-1026-x","article-title":"Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma","volume":"13","author":"El Shafie","year":"2018","journal-title":"Radiat Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2026.101260_bb0130","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/s41591-023-02586-z","article-title":"Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses","volume":"29","author":"Chen","year":"2023","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/neuonc\/noaf237","article-title":"A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma","volume":"28","author":"Landry","year":"2026","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.ctro.2026.101260_bb0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/neuonc\/nox166","article-title":"EANO guidelines for the diagnosis and treatment of ependymal tumors","volume":"20","author":"Rud\u00e0","year":"2018","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2026.101260_bb0145","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11912-022-01260-w","article-title":"Ependymoma: evaluation and management updates","volume":"24","author":"Rud\u00e0","year":"2022","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2007.09.037","article-title":"A retrospective study of surgery and reirradiation for recurrent ependymoma","volume":"71","author":"Merchant","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101260_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2018.11.009","article-title":"Re-irradiation of locally recurrent pediatric intracranial ependymoma: experience of the French society of children\u2019s cancer","volume":"132","author":"R\u00e9gnier","year":"2019","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11060-020-03434-7","article-title":"Extent of re-excision, sequence\/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent\/progressive ependymoma","volume":"147","author":"Gupta","year":"2020","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0165","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijrobp.2017.10.002","article-title":"Outcomes after reirradiation for recurrent Pediatric intracranial ependymoma","volume":"100","author":"Tsang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11604-015-0511-5","article-title":"Re-irradiation of recurrent anaplastic ependymoma using radiosurgery or fractionated stereotactic radiotherapy","volume":"34","author":"Murai","year":"2016","journal-title":"Jpn J Radiol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0175","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1227\/neu.0000000000002979","article-title":"Stereotactic radiosurgery for ependymoma in Pediatric and adult patients: a single-institution experience","volume":"95","author":"Yoo","year":"2024","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.radonc.2015.07.023","article-title":"Use of proton therapy for re-irradiation in pediatric intracranial ependymoma","volume":"116","author":"Eaton","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0185","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/neuonc\/noae220","article-title":"Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: an overview","volume":"27","author":"Kotecha","year":"2025","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101260_bb0190","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: proposal from the RANO group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2026.101260_bb0195","first-page":"1550","article-title":"Diagnostic performance of PET and perfusion-weighted imaging in differentiating tumor recurrence or progression from radiation necrosis in posttreatment gliomas: a review of literature","volume":"41","author":"Soni","year":"2020","journal-title":"AJNR Am J Neuroradiol."},{"issue":"4","key":"10.1016\/j.ctro.2026.101260_bb0200","first-page":"941","article-title":"Contrast-enhanced perfusion MR imaging to differentiate between recurrent\/residual brain neoplasms and radiation necrosis","volume":"19","author":"Metaweh","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0205","first-page":"1","article-title":"Repeat stereotactic radiosurgery for locally recurrent brain metastases previously treated with stereotactic radiosurgery: a systematic review and meta-analysis of efficacy and safety","volume":"8","author":"Singh","year":"2022","journal-title":"J Radiosurg SBRT"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0210","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1186\/s12885-025-13677-0","article-title":"Re-resection of brain metastases \u2013 outcomes of an institutional cohort study and literature review","volume":"25","author":"Wasilewski","year":"2025","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11060-021-03872-x","article-title":"Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation","volume":"155","author":"Wilcox","year":"2021","journal-title":"J Neurooncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101260_bb0220","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"issue":"14","key":"10.1016\/j.ctro.2026.101260_bb0225","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1158\/1078-0432.CCR-17-2452","article-title":"Resistance mechanisms to targeted therapies in ROS1 + and ALK + non\u2013small cell lung cancer","volume":"24","author":"McCoach","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11060-015-1937-4","article-title":"Repeated stereotactic radiosurgery for patients with progressive brain metastases","volume":"126","author":"Minniti","year":"2016","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11060-023-04265-y","article-title":"Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS)","volume":"162","author":"Yan","year":"2023","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0245","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijrobp.2013.10.003","article-title":"Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection","volume":"88","author":"Kurtz","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"21","key":"10.1016\/j.ctro.2026.101260_bb0250","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.3390\/cancers14215293","article-title":"Re-whole brain radiotherapy may be one of the treatment choices for symptomatic brain metastases patients","volume":"14","author":"Ono","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101260_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00551","article-title":"Repeated courses of radiosurgery for new brain metastases to defer whole brain radiotherapy: feasibility and outcome with validation of the new prognostic metric brain metastasis velocity","volume":"8","author":"Fritz","year":"2018","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13014-022-02194-0","article-title":"Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients","volume":"18","author":"Kuntz","year":"2023","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0265","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"issue":"Supplement_4","key":"10.1016\/j.ctro.2026.101260_bb0270","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaf194","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2018\u20132022","volume":"27","author":"Price","year":"2025","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0275","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/neuonc\/noz225","article-title":"Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International stereotactic radiosurgery society practice opinion","volume":"22","author":"Kotecha","year":"2020","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/cen.14127","article-title":"Current perspectives on recurrent pituitary adenoma: the role and timing of surgery vs adjuvant treatment","volume":"92","author":"Hayhurst","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0285","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00701-024-06341-2","article-title":"Long-term tumor control following repeat gamma-knife radiosurgery of growing pituitary adenomas: a population-based cohort study","volume":"166","author":"Lindberg","year":"2024","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.ctro.2026.101260_bb0290","article-title":"Characteristic of tumor regrowth after gamma knife radiosurgery and outcomes of repeat gamma knife radiosurgery in nonfunctioning pituitary adenomas","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101260_bb0295","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.rpor.2014.09.004","article-title":"Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas","volume":"21","author":"Minniti","year":"2016","journal-title":"Rep Pract Oncol Radiother"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0300","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/neuros\/nyy178","article-title":"Stereotactic radiosurgery for acromegaly: an international Multicenter retrospective cohort study","volume":"84","author":"Ding","year":"2019","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0305","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11060-016-2105-1","article-title":"Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus","volume":"128","author":"Iwata","year":"2016","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101260_bb0310","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3171\/2013.7.JNS13217","article-title":"Results of gamma knife surgery for Cushing\u2019s disease","volume":"119","author":"Sheehan","year":"2013","journal-title":"J Neurosurg"},{"issue":"1\u20132","key":"10.1016\/j.ctro.2026.101260_bb0315","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.wneu.2013.01.127","article-title":"Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report","volume":"82","author":"Grant","year":"2014","journal-title":"World Neurosurg"},{"issue":"Suppl. 3","key":"10.1016\/j.ctro.2026.101260_bb0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3171\/jns.2000.93.supplement_3.0010","article-title":"Gamma knife radiosurgery as a primary treatment for prolactinomas","volume":"93","author":"Pan","year":"2000","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0325","doi-asserted-by":"crossref","first-page":"21607","DOI":"10.1038\/s41598-024-72944-5","article-title":"Risk factor analysis and prediction model to establish recurrence or progression of non-functioning pituitary adenomas in men after transnasal sphenoidal surgery","volume":"14","author":"Zhong","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ctro.2026.101260_bb0330","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000339823","article-title":"Natural history of postoperative nonfunctioning pituitary adenomas: a systematic review and meta-analysis","volume":"96","author":"Chen","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0335","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-10-0255","article-title":"Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients","volume":"163","author":"Brochier","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ctro.2026.101260_bb0340","doi-asserted-by":"crossref","unstructured":"O'Sullivan EP, Woods C, Glynn N, Behan LA, Crowley R, O'Kelly P, et al. The natural history of surgically treated but radiotherapy-na\u00efve nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf) 2009;71(5):709\u201314. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03583.x.","DOI":"10.1111\/j.1365-2265.2009.03583.x"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11060-020-03579-5","article-title":"Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas","volume":"149","author":"Minniti","year":"2020","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101260_bb0350","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11102-013-0541-x","article-title":"Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas","volume":"17","author":"Verma","year":"2014","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0355","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ncpendmet1051","article-title":"Radiation-induced hypopituitarism after cancer therapy: who, how and when to test","volume":"5","author":"Darzy","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ctro.2026.101260_bb0360","article-title":"Examination of the dose-effect relationship of radiation-induced hypopituitarism: results of a case-control study","volume":"6","author":"Vakilian","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0365","article-title":"Adrenocorticotropic hormone secreting pituitary carcinoma: rare, durable response to concurrent chemotherapy and reirradiation with a review of the literature","volume":"7","author":"Orr","year":"2022","journal-title":"Adv Radiat Oncol"},{"issue":"1107","key":"10.1016\/j.ctro.2026.101260_bb0370","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190237","article-title":"Proton therapy for brain tumours in the area of evidence-based medicine","volume":"93","author":"Weber","year":"2020","journal-title":"Br J Radiol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101260_bb0375","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00066-022-01973-8","article-title":"DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment","volume":"198","author":"Bernhardt","year":"2022","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101260_bb0380","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2016.08.039","article-title":"Association between radiation necrosis and tumor biology after stereotactic radiosurgery for brain metastasis","volume":"96","author":"Miller","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101260_bb0385","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noag153","article-title":"The European association for neuro-oncology (EANO) consensus statement on radiation necrosis","author":"Duerinck","year":"2026","journal-title":"Neuro Oncol"},{"issue":"Supplement_1","key":"10.1016\/j.ctro.2026.101260_bb0390","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/neuonc\/noad188","article-title":"The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases","volume":"26","author":"Mayo","year":"2024","journal-title":"Neuro Oncol"},{"issue":"19","key":"10.1016\/j.ctro.2026.101260_bb0395","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1158\/1078-0432.CCR-24-1215","article-title":"Decoding patient heterogeneity influencing radiation-induced brain necrosis","volume":"30","author":"Chamseddine","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctro.2026.101260_bb0400","doi-asserted-by":"crossref","first-page":"109422","DOI":"10.1016\/j.radonc.2022.11.011","article-title":"Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients","volume":"178","author":"Eulitz","year":"2023","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0405","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijrobp.2025.09.059","article-title":"A mechanistic model of brain necrosis progression based on vascular heterogeneity","volume":"124","author":"Cogno","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0410","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13014-021-01767-9","article-title":"Current status and recent advances in reirradiation of glioblastoma","volume":"16","author":"Minniti","year":"2021","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0415","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-6-48","article-title":"Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0420","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0425","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2023.07.040","article-title":"Dose-volume tolerance of the brain and predictors of radiation necrosis after 3-fraction radiosurgery for brain metastases: a large single-institutional analysis","volume":"118","author":"Upadhyay","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0430","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijrobp.2021.09.003","article-title":"Hypofractionated stereotactic radiation therapy for intact brain metastases in 5 daily fractions: effect of dose on treatment response","volume":"112","author":"Myrehaug","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101260_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109920","article-title":"Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy","volume":"189","author":"Hall","year":"2023","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0440","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2025.09.008","article-title":"ESMO\u2013ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors","volume":"37","author":"van Aken","year":"2026","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101260_bb0445","first-page":"132","article-title":"High-dose re-irradiation of intracranial lesions \u2013 efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose calculation","volume":"27","author":"Stiefel","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101260_bb0450","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/nop\/npae040","article-title":"Controversies in neuro-oncology: focal proton versus photon radiation therapy for adult brain tumors","volume":"11","author":"Eekers","year":"2024","journal-title":"Neuro-oncol Pract"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0455","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semradonc.2017.11.005","article-title":"Robust proton treatment planning: physical and biological optimization","volume":"28","author":"Unkelbach","year":"2018","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101260_bb0460","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/neuonc\/nos307","article-title":"Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies","volume":"15","author":"Verma","year":"2013","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101260_bb0465","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2026.101260_bb0470","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s11604-025-01821-6","article-title":"RANO 2.0: critical updates and practical considerations for radiological assessment in neuro-oncology","volume":"43","author":"Sakata","year":"2025","journal-title":"Jpn J Radiol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0475","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101260_bb0480","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/CCO.0000000000000793","article-title":"Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis","volume":"33","author":"Nichelli","year":"2021","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0485","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3174\/ajnr.A1377","volume":"30","author":"Hu","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101260_bb0490","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/jmri.25837","article-title":"Relative cerebral blood volume is a potential biomarker in late delayed radiation-induced brain injury","volume":"47","author":"Xie","year":"2018","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"10.1016\/j.ctro.2026.101260_bb0495","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3174\/ajnr.A5952","article-title":"Utility of dynamic susceptibility contrast perfusion-weighted MR imaging and 11 C-methionine PET\/CT for differentiation of tumor recurrence from radiation injury in patients with high-grade gliomas","volume":"40","author":"Qiao","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101260_bb0500","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2967\/jnumed.122.264859","article-title":"Amino acid PET in Neurooncology","volume":"64","author":"Galldiks","year":"2023","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0505","article-title":"Contrast clearance analysis in neuro-oncology: a systematic review and meta-analysis on differentiating posttreatment changes from tumor progression","volume":"7","author":"Tahamtan","year":"2025","journal-title":"Neurooncol Adv"},{"issue":"1","key":"10.1016\/j.ctro.2026.101260_bb0510","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijrobp.2023.07.015","article-title":"A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and international stereotactic radiosurgery society recommendations","volume":"118","author":"Vellayappan","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2026.101260_bb0515","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2026.101260_bb0520","article-title":"Boswellia serrata for the Management of Radiation-Induced Cerebral Edema and Necrosis: a systematic Meta-narrative review of clinical evidence","volume":"10","author":"Dejonckheere","year":"2025","journal-title":"Adv Radiat Oncol"},{"issue":"16","key":"10.1016\/j.ctro.2026.101260_bb0525","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1002\/cncr.25945","article-title":"Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors","volume":"117","author":"Kirste","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ctro.2026.101260_bb0530","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ijrobp.2025.02.016","article-title":"Boswellia Serrata for cerebral radiation necrosis after radiosurgery for brain metastases","volume":"122","author":"Upadhyay","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2026.101260_bb0535","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11060-020-03570-0","article-title":"Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases","volume":"148","author":"Sujijantarat","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ctro.2026.101260_bb0540","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.wneu.2024.01.161","article-title":"Hyperbaric oxygen therapy as an alternative therapeutic option for radiation-induced necrosis following radiotherapy for intracranial pathologies","volume":"186","author":"Hajikarimloo","year":"2024","journal-title":"World Neurosurg"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:06:02Z","timestamp":1793743562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":108,"alternative-id":["S2405630826001552"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101260","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reirradiation of recurrent brain tumors: a review by the ESTRO CNS Focus Group","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101260"}}